Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Mukka Proteins
Small Cap•314 Employees•IPO 2024
Current Price
₹22.93
0.26 (1.15%)Updated
Today's Range
22.65
₹22.93
23.53
52 Week Range
52W Low₹20.16
52W High₹36.73
₹22.93
Downside13.74%
Upside60.18%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹742.5 Cr
Market Cap
Total market value of companyP/E Ratio
16.81
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
2.23
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹1.45
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
-%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
11.60%
ROCE
Return on Capital Employed. >15% is goodNet Margin
4.79%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
-%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
-1.00%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
-64.10%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
1.03
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹14.69
Book Value
Net asset value per shareDividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
73.30%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
2 points- •Mukka Proteins exhibits strong promoter confidence with a substantial promoter holding of 73.33% as of September 2025, indicating a stable and committed leadership in the company's long-term vision.
- •The company's Price-to-Earnings (P/E) ratio of 17.50 is slightly below the sector P/E of 18.78, suggesting a potentially attractive valuation compared to its industry peers for investors.
Weaknesses
5 points- •Mukka Proteins experienced a substantial decline in its latest quarterly net profit by 64.07% to 1.59 Cr, indicating significant operational challenges and a concerning trend in recent profitability.
- •The company's debt-to-equity ratio stands at 1.03, suggesting a relatively high reliance on debt financing, which could increase financial risk and interest burden for the company.
Opportunities
2 points- •Despite recent sales decline, the broader Animal Feed industry, where Mukka operates, shows growth among peers, indicating potential for market expansion and recovery for the company.
- •With a Price-to-Book Value of 1.71, the company might be considered undervalued relative to its assets, potentially offering an attractive entry point for long-term investors.
Threats
2 points- •Mukka Proteins faces intense competition from larger and more profitable peers like Avanti Feeds and Godrej Agrovet, which exhibit stronger ROCE and sales growth, posing market share risks.
- •An increasing public shareholding, rising from 18.21% to 23.31% over the past year, could lead to higher stock price volatility and reduced stability in the shareholder base.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹25.18 | +₹2.25 | +9.83% |
| R3 | ₹24.30 | +₹1.37 | +5.99% |
| R2 | ₹23.92 | +₹0.99 | +4.30% |
| R1 | ₹23.42 | +₹0.49 | +2.15% |
| PIVOT | ₹23.04 | 0.11 | 0.47% |
| CURRENT | ₹22.93 | - | - |
| S1 | ₹20.78 | -₹2.15 | -9.36% |
| S2 | ₹21.66 | -₹1.27 | -5.52% |
| S3 | ₹22.16 | -₹0.77 | -3.37% |
| S4 | ₹22.54 | -₹0.39 | -1.69% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume-38.1% vs avg
2.77L
(11 Mar 2026)Delivery %+1.6% vs avg
50.1%
(11 Mar 2026)Avg Volume (20D)20-day average
4.48L
(11 Feb - 11 Mar)Avg Delivery %Trend ↑
48.6%
(11 Feb - 11 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Nestle India Ltd
2.48L ₹ Cr
Best Profit Growth
Uttam Sugar Mills Ltd
150.00 %
Highest Dividend Yield
Avadh Sugar & Energy Ltd
2.95 %
Peer Comparison
| Company Name |
|---|
 Apex Frozen Foods Ltd |
 Avadh Sugar & Energy Ltd |
 BCL Industries Ltd |
 Dhampur Bio Organics Ltd |
 Dhampur Sugar Mills Ltd |
 Dwarikesh Sugar Industries Ltd |
 Euro India Fresh Foods Ltd |
 Foods & Inns Ltd |
 |
 |
 Magadh Sugar & Energy Ltd |
 Mcleod Russel India Ltd |
 Nestle India Ltd |
 |
 Sarveshwar Foods Ltd |
 Uttam Sugar Mills Ltd |
 Zuari Industries Ltd |
About
Mukka Proteins Ltd
Mukka Proteins Limited is an Indian company specializing in the manufacturing and sale of fish-based protein products. Their core business centers around providing high-quality ingredients derived from fish processing, serving a diverse range of industries both domestically and internationally.
The company's product portfolio includes key components like fish meal, fish oil, and fish soluble paste. These products are primarily utilized as valuable ingredients in the animal feed sector, catering to the needs of animal feed manufacturers, pet food producers, and aquaculture farms. This represents a significant portion of their business operations and highlights their role in supporting the food production industry.
Beyond fish-based products, Mukka Proteins has expanded its offerings to include insect meal and insect oil. This diversification reflects a growing trend towards sustainable and alternative protein sources within the animal feed industry. The inclusion of insect-derived products demonstrates Mukka Proteins' commitment to innovation and adapting to evolving market demands.
The applications of Mukka Proteins' products extend beyond animal feed. Their diverse product range also finds use in various other industries, including pharmaceuticals, soap manufacturing, leather tanning, and even the paint industry. This broad application demonstrates the versatility and value of their products across multiple sectors, contributing to their robust business model.
Mukka Proteins has established a significant international presence, exporting its products to a wide array of countries including Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, the Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam. This global reach underscores the company's success in meeting the international demand for high-quality protein ingredients.
With a history dating back to 1960, Mukka Proteins (formerly Mukka Sea Food Industries Limited) has a long-standing presence in the industry. Based in Mangalore, India, the company continues to build upon its legacy of providing essential ingredients to a broad range of industries, both domestically and across international markets.
COMPANY FACTS - MUKKA
Registered Address
Mukka Corporate House Door No. 18-2-16/4, First cross, NG Road, Attavara, Mangaluru
Mangalore
KARNATAKA
IN
Tel: 919845522899
Website:https://www.mukkaproteins.com
Investor Relations:https://www.mukkaproteins.com/Investors-annual-return.php
Company Details
Group: Food, Beverage & Tobacco
Sector: Consumer Staples
Industry: Food Products
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 314
IPO Date: 07/03/2024
MANAGEMENT - MUKKA
Mr. Kalandan Haris
Chief Executive Officer, Managing Director (Promoter)
Mr. Kalandan Althaf
Chief Financial Officer, Whole-Time Director (Promoter)
Mr. Mehaboobsab Chalyal
Compliance Officer, Company Secretary
Mr. Kalandan Arif
Whole-Time Director (Promoter)
Mrs. Umaiyya Banu
Director (Promoter)
Mr. Kalandan Razak
Director (Promoter)
Mr. Karkala Balachandra Rao
Independent Director
Mr. Hamad Bava
Independent Director
Mr. Narendra Kamath
Independent Director
Investor Questions Answered
Mukka Proteins Ltd (MUKKA) Stock FAQs
Get answers to the most common questions about Mukka Proteins Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Mukka Proteins Ltd (MUKKA) is ₹22.93. Today, the stock has gained by ₹0.26 (1.15%), trading in a range of ₹22.65 to ₹23.53. The stock opened at ₹22.7 with a trading volume of 2,77,469 shares.
Mukka Proteins Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹742.5 crores, P/E ratio of 16.81, ROE of 0.00%, and ROCE of 11.60%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Mukka Proteins Ltd (MUKKA) is ₹36.73, while the 52-week low is ₹20.16. Currently trading at ₹22.93, the stock is 16.7% away from its 52-week low and 37.6% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Mukka Proteins Ltd stock at ₹22.93 depends on multiple factors. The stock is currently trading with a P/E ratio of 16.81 and P/B ratio of N/A. Today's performance shows a gain of 1.15%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Mukka Proteins Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹22.93, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Mukka Proteins Ltd's key financial metrics include: P/E Ratio: 16.81, P/B Ratio: N/A, ROE: 0.00%, ROCE: 11.60%, Dividend Yield: 0.00%, EPS: ₹1.45, Book Value: ₹14.69, Debt-to-Equity: 1.03, and Current Ratio: N/A. The company's market cap stands at ₹742.5 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Mukka Proteins Ltd stock opened at ₹22.7 and is currently trading at ₹22.93, showing a gain of ₹0.26 (1.15%). The intraday high is ₹23.53 and low is ₹22.65. The trading volume stands at 2,77,469 shares, indicating moderate market participation today.
Mukka Proteins Ltd has a Price-to-Earnings (P/E) ratio of 16.81, which means investors are willing to pay ₹16.81 for every ₹1 of earnings. With an EPS of ₹1.45, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
Mukka Proteins Ltd has a market capitalization of ₹742.5 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹22.93) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Mukka Proteins Ltd has a book value of ₹14.69 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹22.93, which is 56.1% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Mukka Proteins Ltd has a Return on Equity (ROE) of 0.00% and Return on Capital Employed (ROCE) of 11.60%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Mukka Proteins Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Mukka Proteins Ltd has a debt-to-equity ratio of 1.03, which measures the company's financial leverage by comparing total debt to shareholders' equity. A ratio above 1 suggests the company uses more debt than equity for financing. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Mukka Proteins Ltd has an Earnings Per Share (EPS) of ₹1.45, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹22.93 and P/E ratio of 16.81, investors are paying 16.81 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Mukka Proteins Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Mukka Proteins Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Mukka Proteins Ltd stock, consider: 1) Fundamental Analysis - Review P/E (16.81), ROE (0.00%), debt-to-equity (1.03), and growth rates. 2) Technical Analysis - Check 52-week range (₹20.16 - ₹36.73), moving averages, and chart patterns. 3) Valuation - Compare current price (₹22.93) with book value (₹14.69) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Mukka Proteins Ltd share is ₹1.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹22.93 is 2193x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Mukka Proteins Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹20.16 - ₹36.73). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 1.03 indicates leverage. 4) Liquidity Risk - Based on trading volume of 2,77,469 shares. 5) Valuation Risk - P/E of 16.81 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Mukka Proteins Ltd operates in the industry with key metrics: P/E ratio of 16.81, ROE of 0.00%, market cap of ₹742.5 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 1.03), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Mukka Proteins Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹22.93, with a 52-week range of ₹20.16 to ₹36.73. Based on fundamentals like P/E (16.81), ROE (0.00%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Mukka Proteins Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹22.93. 2) Fundamental Deterioration - Declining ROE (currently 0.00%), increasing debt (D/E: 1.03), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Mukka Proteins Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu